NCT00003166 - Bryostatin and Vincristine in B-Cell Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

July 31, 2001

Conditions

Recurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult Lymphoblastic LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Multiple MyelomaStage III Multiple Myeloma

Interventions

DRUG

bryostatin 1

Given IV

DRUG

vincristine sulfate

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

44106

Case Western Reserve University, Cleveland

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH